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Abstract
High-performance liquid chromatography/mass spectrometry (HPLC/MS) is sensitive and specific 
for targeted quantitative analysis and is readily utilized for small molecules from biological 
matricies. This brief review describes recent selected HPLC/MS methods for the determination of 
urinary mercapturic acids (mercapturates) which are useful as biomarkers in characterizing human 
exposure to electrophilic industrial chemicals in occupational and environmental studies. 
Electrophilic compounds owing to their reactivity are used in chemical and industrial processes. 
They are present in industrial emissions, are combustion products of fossil fuels, and are 
components in tobacco smoke. Their presence in both the industrial and general environment are 
of concern for human and environmental health. Urinary mercapturates which are the products of 
metabolic detoxification of reactive chemicals provide a non-invasive tool to investigate human 
exposure to electrophilic toxicants. Selected recent mercapturate quantification methods are 
summarized and specific cases are presented. The biological formation of mercapturates is 
introduced and their use as biomarkers of metabolic processing of electrophilic compounds is 
discussed. Also, the use of liquid chromatography/tandem mass spectrometry in simultaneous 
determinations of the mercapturates of multiple parent compounds in a single determination is 
considered, as well as future trends and limitations in this area of research.
Keywords
liquid chromatography; mass spectrometry; occupational exposure; industrial chemicals; urinary 
biomarker; mercapturic acid
Disclaimers: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the 
National Institute for Occupational Safety and Health (NIOSH) or the Centers for Disease Control and Prevention (CDC). Mention of 
company names and/or products does not constitute an endorsement by NIOSH.
Declaration of Interest
The authors hereby report that we have no conflict of interest with the material reported in this paper. The authors alone are 
responsible for the content and writing of this paper.
HHS Public Access
Author manuscript
J Chromatogr B Analyt Technol Biomed Life Sci. Author manuscript; available in PMC 2015 
August 10.
Published in final edited form as:















The detection and quantitation of urinary mercapturic acids (mercapturates) has become an 
important tool in characterizing human exposure to occupational and environmental 
toxicants. Although environmental exposure may be determined by air or water 
concentrations, estimations of internal dose of a toxicant in individuals based on these 
external measures are imprecise due to variations in toxicant adsorption and metabolism [1]. 
Concentrations found in the general environment do not often correlate to an individual’s 
internal dose and various estimates based on models may not be accurate. Determination of 
urinary mercapturates, which are the products of toxicant metabolism, provide useful 
biomarkers of individual toxicant absorption and internal dose [2]. The use of mercapturates 
as biomarkers of toxic occupational and environmental exposure has been extensively 
reviewed [1, 2] and a survey of HPLC separation and mass spectrometry techniques to 
quantitate these biomarkers has been undertaken here.
Figure 1 shows a simplified and condensed illustration of mercapturic acid formation [3]. 
First, glutathione (GSH), an endogenous tripeptide, reacts to inactivate an electrophilic 
toxicant or toxicant metabolite either spontaneously or by catalysis with glutathione 
transferase in the liver and in other organs. Next glutamyl and glycine moieties are 
enzymatically removed to form a cysteine conjugate. This conjugate is, in turn, N-acetylated 
to form what is generally a toxicant-specific mercapturate [3]. The initial reaction between 
endogenous GSH and an electrophilic moiety on a compound is regarded as a detoxification 
step, and prevents reaction of the electrophilic metabolite with cellular components such as 
proteins, lipids or DNA. The final N-acetylation reaction increases the polarity and 
hydrophilicity of the metabolite, making it more water soluble and allowing for urinary 
excretion and elimination [1, 2].
In the interest of brevity, the mercapturate names shown in Table 1 and used throughout this 
review are truncated from the systematic name of the S-conjugated electrophilic group 
except in the cases of acrylamide and the triazine and chloroacetamide herbicide derived 
mercapturates. Thus the systematic name for the mercapturate of benzene, N-acetyl-S-
(phenyl)-L-cysteine is shortened to phenyl mercapturate. The abbreviations used for 
mercapturates vary throughout the current literature, and are generally derived from the S-
conjugated electrophilic group. The abbreviations used in this review, as they appear in the 
cited methods, are listed in Table 1 by parent compound.
This review describes selected HPLC-MS methods for determination of mercapturates as 
biomarkers in characterizing human exposure to industrial chemicals for the support of 
occupational and environmental studies. The mercapturate biomarkers considered here are 
the detoxification products of a wide range of heterogenous electrophilic compounds (Table 
1) and no single analytical approach for development of a method for a new specific 
mercapturate can be recommended. Alternatively, this work is a survey of the multiple 
analytical approaches described in recently published HPLC/MS mercapturate 
determinations.
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Although Perbellini et al. [3] reviewed methods in 2002 for determining mercapturates in 
biological exposure monitoring, the scope of their review included gas chromatographic 
(GC), and high-performance liquid chromatographic (HPLC) methods, including mass 
spectrometric detection, and it was limited to single mercapurates of benzene, toluene and 
xylene, as well as the detection of two of the mercapturate products of 1,3-butadiene and of 
trimethylbenzene [3]. The current review focuses on single and tandem mass spectrometric 
detection with various modes of HPLC separation on a broader range of mercapturate 
compounds. Selected representative mercapturate methods, the targeted mercapturate(s), 
with the labeled internal standards employed and their m/z values or mass transitions for 
quantitation are summarized in tabular format and highlights briefly described in section 2. 
An overview of mercapturates as biomarkers of parent compound metabolic activation, as 
specific indicators of toxicant exposure, and as tools to investigate toxicant metabolism and 
elimination will be presented in section 3 of the current review. Section 4 will consider 
simultaneous determination of target mercapturates of multiple parent compounds in a single 
chromatographic analysis.
2. Tabular summaries of selected methods
Tables 2 and 3 summarize some of the numerous HPLC-MS methods reported for the 
detection and quantification of various mercapturates used in occupational and 
environmental studies. The terminology and abbreviations appearing in these tables indicate 
sample preparation techniques, chromatographic conditions, and mass spectrometry 
detection modes reported for these methods and are explained in more detail in the 
following sections of this review.
2.1. Sample preparation techniques
The specific and reproducible quantification of mercapturates by HPLC/MS presents a series 
of challenges. Analytes must be separated from substances in the urinary matrix that may 
interfere with specific detection either by altering the intensity of the analyte signal or co-
eluting with the target mercapturate, making sample preparation as critical to success as any 
other part of the analysis. In the methods reviewed, a variety of sample preparation 
techniques are described with the simplest being dilution and filtration through 0.2 μ 
cellulose medium followed by direct injection [12]. Other techniques use sample 
concentration with re-suspension in methanol or acetonitrile, or protein precipitation by 
acidification and centrifugation prior to analysis [9, 16, 19, 21]. Most methods utilize 
manual solid phase extraction (SPE), while four methods utilize online sample extraction 
with column switching, where urine is passed through a trap using an online multiple valve 
[5–8]. Small target analytes are retained in the trap. When valve positions are switched, 
urinary proteins and salts are washed away to waste. A final switching of valves with a 
change to elution buffer carries analytes from the trap to the LC column for separation. 
Various SPE media may be employed to extract and concentrate target mercapturates from 
the urinary matrix: reversed phase (RP), reversed phase-strong anion exchange (RP-WAX) 
[15] or restricted access medium (RAM) phase online trap cartridges [5–8]. Restricted 
access media are specialized chromatographic phases that combine size-exclusion with other 
retention mechanisms. Internal surface-reversed phase RAM combines silica gel particles 
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having inner pores functionalized to retain small molecules (C18, C8 or C4) with an outer 
hydrophilic surface such as methyl cellulose.
Online sample extraction using SPE traps with column switching has grown in popularity to 
create automated analyses that decrease overall analysis time by a substantial reduction in 
sample preparation steps. This trend is likely to continue to grow in the future as better 
automated systems become commercially available. Online SPE-LC-MS/MS method design 
and optimization has been described by Kuklenyik et al. [24] presenting three example 
applications including a determination of two mercapturates of atrazine. Online SPE-LC-
MS/MS has been used extensively by Schettgen and collaborators [25–28] in simultaneous 
determinations of biomarker mercapturates of aromatic compounds and volatile alkylating 
agents. Here rapid automated sample extraction and μg/L sensitivity are combined in 
methods developed for investigation of occupational exposure and environmental exposure 
in general populations to tobacco smoke and urban air pollutants.
A second form of SPE designed to speed sample through-put uses a 96-well plate format 
described by Mallet et al.[29] Li et al. [30] and Barbieri et al. [31] used strong anion 
exchange media in this format to increase extraction throughput in analyses of benzene and 
toluene mercapturates for studies of benzene exposure in smokers and gas station workers. 
Recently, Kuklenyik et al. [32] described a 96-well plate sample extraction and sample 
handling mode used in analysis of four atrazine mercapturates for non-occupational 
exposure studies. The authors describe rapid optimization of sample extraction parameters, 
selecting between four extraction eluate compositions to increase analyte stability and 
maximize MS/MS signal intensity. Following extract elution into 2 μL square wells, further 
extract transfer and handling were eliminated by evaporation of extracts under nitrogen in 
the sample wells. Evaporated extracts were stored up to four days without sample 
degradation before reconstitution immediately before analysis. Like SPE-RAM, this format 
may be adapted to online analysis when high-throughput and the speed of fully automated 
analysis are necessary.
2.2. Liquid chromatography
2.2.1. Reversed-phase chromatography—Mercapturate metabolite analysis methods 
typically employ reversed-phase (RP) columns having C18, C8 or C4 stationary phases. 
Commonly used mobile phases contain volatile acids or buffers such as formic acid 
(HCOOH), acetic acid (CH3COOH), ammonium formate (HCOONH4), or ammonium 
acetate (CH3COONH4). Organic modifiers such as methanol (MeOH) and acetonitrile 
(ACN) are commonly used with either isocratic or gradient conditions for analyte elution. 
Mixed mode separation has also been reported in the literature. Kotapati et al. [15] 
combined RP and weak anionic exchange to determine THBMA a mercapturate metabolite 
of 1,3-butadiene.
2.2.2. Ultra-high performance chromatography—Other technological improvements 
have been made in chromatographic analysis and have been applied to mercapturic acid 
metabolite determination. Ultra-high performance liquid chromatography (UHPLC) has 
come into use for biomarker monitoring owing to the fact that most HPLC pump 
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manufacturers are offering pumping systems capable of maintaining the high back pressure 
levels required for the technique. Standard HPLC pumping systems have traditionally had 
maximum pressure levels of approximately 400 Bar (Atmospheres) while UHPLC pumps 
are designed to handle pressures in excess of 1000 Bar. Alwis et al. [21] developed a 
chromatographic procedure to determine 24 mercapturate metabolites of 15 VOCs in the 
human urine using UHPLC. Alwis used a capillary 2.1 mm diameter by 150 mm column 
containing 1.8 μm spherical C18 bonded silica. Although UHPLC utilizes a smaller particle 
size and smaller column diameter, it provides sharper peaks while decreasing sample 
loading over conventional HPLC. The number of theoretical plates should be increased by 
the use of UHPLC. This in turn may provide greater sensitivity by increasing the signal to 
noise ratio of the detector. The mass spectrometer is a mass sensitive detector, not 
concentration dependent such as in ultraviolet detection; therefore, UHPLC may in some 
cases match or exceed the sensitivity of standard chromatographic systems.
2.2.3. Hydrophilic interaction chromatography—One of the most important recent 
trends in mercapturic metabolite analysis is the use of hydrophilic interaction 
chromatography (HILIC). RP chromatography is common with electrospray ionization MS 
(ESI-MS) but has the major limitation in the lack of retention of highly hydrophilic, ionic or 
polar molecules on the stationary phase. Ordinarily normal phase (NP) would be used to 
satisfy the separation conditions of highly polar analytes, but NP is not easily made 
compatible with ESI-MS. HILIC utilizes a polar stationary phase with an aqueous/polar 
organic solvent mobile phase, where water is introduced to play the role of a stronger eluting 
solvent. HILIC overcomes the mismatch between the NP like chromatography and the ESI-
MS. Hemstrom and Irgum [33] have described HILIC mechanism in great detail, and 
Nguyen and Schug [34] have described the advantages of HILIC when combined with ESI-
MS detection. The application of HILIC in quantitative bioanalysis of compounds of 
pharmaceutical interest has been described by Jian et al. [35].
HILIC columns have been reported in the literature for the determination of more polar 
mercapturates [7, 12, 16, 20]. In HILIC separations, mercapturates are separated from 
urinary matrix by a partitioning mechanism between a water-enriched layer associated with 
a polar stationary phase and solvent containing ammonium formate or ammonium acetate 
and 5–15% water to maintain the water-enriched layer on the stationary phase. Since 
retention increases with hydrophilicity and polarity of the analyte, elution is driven by 
increasing water content in the mobile phase which is composed of high organic content, 
usually consisting of acetonitrile or alternatively, methanol.
Biomonitoring of worker exposure to electrophilic alkylating agents, such as 
acrylamide[36], acrylonitrile [37], and 1,3-butadiene [16, 38], that are carcinogenic, is 
important in industrial medicine [1, 2]. The mercapturates of these compounds are polar, 
especially those containing hydroxylalkyl groups that are difficult to retain on RP columns 
without using highly aqueous conditions and non-volatile mobile phase components. Such 
conditions are not ideal for analyte ionization by electrospray (ES). Typically HILIC mobile 
phases using a high organic phase (> 80%) are ideal for ESI-MS analysis, and may enhance 
ES-MS response [34]. HILIC-ESI-MS appears to be a useful technique, and has been used 
as a complement to RPLC-ESI-MS studies by Dekant and collaborators [6,7] in 
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complementary studies of acrylamide and glycidamide mercapturates and other polar 
acrylamide metabolites (Table 2). Kopp et al. [7] used HILIC-ESI-MS to achieve baseline 
separation between two acrylamide metabolites, AAMA-sulfoxide and GAMA. Failure to 
resolve these two metabolites could result in over estimation of urinary GAMA levels, and 
hence an over estimation of the potential risk of AA exposure in humans. Yan [12] 
developed a direct-injection method using HILIC to eliminate sample extraction used in 
earlier methods [10,11] to quantitate the acrolein mercapturate 3-HPMA. The method 
specificity, linearity, precision and accuracy met required FDA criteria [39]. Sterz et al. [16], 
and Eckert et al. [20] both employed HILIC chromatography to simultaneously determine 
multiple hydroxyalkyl mercapturates of alkylating agents. These studies are considered 
below in section 4 describing simultaneous determinations.
2.3. Detection Modes by MS and MS/MS
The basic function of a mass spectrometer is to measure the mass-to-charge ratios (m/z) of 
analyte ions. Mass spectrometers have various designs which have been reviewed elsewhere 
in the literature [40]. Although mass spectrometers are capable of scanning for use in 
qualitative identification of compounds, the monitoring of specific ions for quantitation is 
the focus of this discussion. For the mercapturic acid metabolite analyses surveyed for this 
review, single quadrupole (SQ) mass analyzers and tandem mass spectrometers using the 
triple quadrupole (QQQ) design dominate what is reported in the literature (Tables 2–3). 
The mass analyzer of the spectrometer has the function to separate the formed precursor 
ions. Analysis of analytes using single quadrupole instruments are performed in Selected Ion 
Monitoring (SIM) mode in which only a selected m/z value is detected in the analysis. The 
majority of the methods found in this review employ tandem transmission quadrupole 
instruments (MS/MS). In the case of multiple mercapturic acid metabolite analysis, all use 
the QQQ in which precursor ions are selected in the first quadrupole and allowed to pass 
into a collision chamber for collision-induced dissociation fragmentation into product ions. 
Transmitted from the collision chamber, fragmentation product ions will pass into the third 
quadrupole for detection in the Selected Reaction Monitoring (SRM) mode or multiple 
product ions may be detected in the Multiple Reaction Monitoring (MRM) mode. The use of 
tandem mass spectrometry allows for the greatest level of sensitivity and specificity for the 
analysis method. The increased sensitivity level of the MS/MS detection mode is of 
particular importance in environmental investigations of ubiquitous low-level industrial 
pollutant exposures encountered in the general environment where levels of urinary 
mercapturates are in μg/L or ng/L levels.
3. Mercapturates as biomarkers of metabolic processing
The metabolism of electrophilic compounds in individuals varies with toxicant dose, 
absorption and enzyme polymorphisms [1, 2]. The excretion of mercapturates subsequently 
varies and their quantitation can provide information about individual occupational and 
environmental exposure, internal dose and metabolism, including metabolic activation of an 
electrophilic compound into multiple metabolites many of which may react with GSH to 
later form a mercapturate. The determination of one or more of the mercapturate products of 
a parent compound may be required for informative biomonitoring [1, 2]. The metabolism of 
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some common hazardous chemicals will be described briefly; these include acrylamide, 
acrylonitrile, 1,3 butadiene, benzene and toluene, and 1-bromopropane. These examples 
demonstrate broadly how mercapturate determination may be used in biomonitoring and in 
the investigation of toxicant metabolism and processing in exposed individuals. Toxicant 
processing may include biological activation, detoxification and elimination of mutagenic or 
carcinogenic toxicants.
3.1. Acrylamide
Acrylamide (AA) is an extensively used industrial chemical intermediate with many 
applications such as a polymerizing agent in grouts or other acrylamide polymers used in 
waste water treatment, soil stabilization and paper manufacture [41]. Low levels of 
acrylamide are present in baked, fired, and roasted foods, and mainstream and sidestream 
tobacco smoke are common sources of human exposure [42]. Both AA and its oxidative 
metabolite glycidamide (GA) contain electrophilic groups capable of binding to cellular 
proteins, a property associated with acrylamide neurotoxicity. Furthermore, glycidamide, a 
reactive epoxide, binds to nucleophilic nucleic acids to form adducts with cellular DNA and 
this mechanism is regarded as the cause of AA carcinogenicity [36]. Thus, in human 
biomonitoring and health risk assessments of AA elimination routes, the metabolism and 
conversion to GA must be considered. LC/MS analysis have been adapted to these purposes, 
and four examples of this are listed in Table 2, [4–7]. A method for simultaneous 
determination of urinary AA and the mercapturate, AAMA, was developed for occupational 
exposure monitoring [4]. As indicated previously, AA exposure is not limited to the 
industrial environment. To examine the health risk posed by AA in food, methods for 
simultaneous quantitation of AAMA and of GA isoform mercapturates, GAMA2 and 
GAMA3, have been developed and reported in the literature during epidemiologic studies 
for dietary AA conversion to GA of non-occupationally exposed populations [6,7].
3.2. Acrylonitrile
Acrylonitrile (AN) a widely-used industrial chemical and component in tobacco smoke, is 
another example of a much studied chemical exposure hazard. Acrylonitrile is not directly 
carcinogenic, but like acrylamide, is potentially carcinogenic through an oxidative 
metabolite, glycidonitrile (GN) [8, 9]. AN may be detoxified by direct GSH conjugation to 
form 2-cyanoethyl mercapturate (CEMA) or alternatively AN may be activated to GN that is 
further metabolized to 2-hydroxyethyl mercapturate (HEMA). Taken together CEMA and 
HEMA quantitation represent conjugative detoxification of AN, while HEMA quantitation 
provides a measure of metabolic activation of AN to the reactive epoxide, GN. Similarly, the 
oxidative metabolism of 1,3-butadiene may result in the formation of 3 reactive epoxides, 
that if not detoxified by GSH conjugation or other mechanism, can react with nucleophilic 
sites in DNA and serve as direct-acting mutagens [38]. Their detoxified mercapturates are 
DHBMA, THBMA, MHBMA1 and MHBMA2 (Table 1). All serve as useful indicators of 
internal nucleophile exposure and metabolic processing in occupational studies [15].
3.3. Benzene and toluene
Benzene and toluene are fairly common solvents encountered in the general environment. 
These solvents are aromatic hydrocarbons and are frequently used in industrial chemicals, as 
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common components in fuels and are components in cigarette smoke. Benzene is a known 
human cancer hazard [43, 44], and the hematotoxicity of benzene has been well elucidated 
during the past few decades [43, 44]. Both chemicals form corresponding mercapturates 
which can be used as biomarkers of exposure. Benzene metabolism forms 
phenylmercapturic acid (PMA) and also forms four other, non-mercapturate metabolites that 
have been investigated as possible biomarkers, but their urinary levels are influenced by the 
metabolism of gut flora, diet, and medication use, and smoking [44]. Similarly, the 
metabolism of toluene forms one mercapturate, benzylmercapturic acid (BMA), and two 
other non-mercapturate metabolites that are influenced by diet and are not specific for 
toluene exposure [45]. Because of the desired quality that a biomarker of exposure should be 
specific for chemical exposure, PMA and BMA that are free of dietary and endogenous 
interferences are preferred biomarkers for benzene and toluene exposure [44, 45]. However, 
both may be influenced by smoking. Therefore, in biomonitoring, study subjects should be 
asked to refrain from smoking for 2 h before urine collection [46].
3.4. 1-Bromopropane
1-Bromopropane (1-BP) is an industrial solvent used as a subsitute for chlorofluorocarbons 
or potential carcinogens in metal electronics degreasing, in adhesives, in aerosol solvents 
and in dry cleaning [47]. Exposure in workers causes central and peripheral neurological 
disorders and changes in cellular blood components [48]. 1-BP metabolism, which has been 
investigated most completely in rodents, produces four mercapturates: one direct GSH 
conjugate, n-propylmercapturate, and three more derived from detoxification by GSH of 
oxidative metabolites produced by cytochrome P450 monooxygenase. Oxidative metabolites 
3-bromopropionic acid [49], 1-bromo-2-propanol and bromoacetone [50] are in turn 
conjugated with glutathione to form 2-carboxyethylmercapturate, 2-
hydroxypropylmercapturate and 2-oxopropylmercapturate, respectively (Figure 2). Research 
performed in this laboratory investigated the use of these mercapturates and one oxidative 
metabolite, 3-bromopropionic acid (3-BPA), as potential biomarkers of 1-BP exposure in 
highly exposed workers [51]. Urinary mercapturates were quantified by HPLC/MS [13] 
where the direct GSH conjugate, n-propylmercapturate was predominated in the most 
heavily exposed worker urine specimens. When the same urine samples were analyzed for 
3-BPA using GC/MS [52], no 3-BPA was detected. This result suggests that 1-BP is directly 
conjugated with GSH, and that oxidative metabolism of 1-BP is not a major metabolic 
pathway in humans. Studies of human metabolism of 1-BP are limited to analysis of n-
propylmercapturate in worker urine [53, 54], and provide no explanation for these 
unexpected results. However recent studies in rodents by Garner et al. [55], demonstrated 
that oxidative metabolism of 1-BP by P450 CYP2E1 becomes saturated in highly exposed 
rats, but not in mice. In rats, 1-BP oxidative metabolism is dose-dependent and becomes 
blocked with increased toxicant dose. As a result, n-propylmercapturate becomes the 
predominate urinary mercapturate. When an inhibitor of oxidative metabolism was given to 
rats, all oxidative metabolites including 3-BPA, were eliminated from their urine, leaving 
only n-propylmercapturate as the predominate urinary metabolite, mirroring the effect of 
metabolite saturation of oxidative pathways that likely occurs in high 1-BP exposure. These 
results suggest a difference between human and rat metabolism of 1-BP and that found in 
mice. In these studies urinary mercapturate identification was used to investigate toxicant 
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metabolism, and to deduce possible changes in the activity of up-stream metabolic pathways 
that occur with changes in the conditions of exposure to toxicants in research animals or in 
exposed workers.
4. Simultaneous determinations of target mercapturates in typical fields
In the past, one of the main technological limitations of mass spectrometers used in HPLC 
analysis has been the rate of data acquisition and the dwell time of monitoring the response 
at specific masses. Low data acquisition rates have been known for many years to lead to 
poor chromatographic peak integration and poor reproducibility of peak area determinations 
[56]. Rapid data acquisition is necessary in order to minimize chromatographic peak 
distortion, which can be a problem with multiple analyte methods or spectral data collected 
from increasingly narrow chromatographic peaks such as with UHPLC. With improvements 
in data aquisition rate for MS systems, mostly from the advent of much more powerful 
personal computers, HPLC-MS methods have been more capable of determining multiple 
mercapturate analytes in a single chromatographic analysis.
4.1. Urban air pollutants
Simultaneous determination analysis is well suited to investigate complex exposures to 
volatile organic compounds (VOC) in occupational settings, in exposure of urban 
populations to air pollutants, and in cigarette smoke [57–59]. Sabatini et al. [22] developed a 
simultaneous determination for the mercapturates of benzene, toluene and xylene (BTX) 
using FDA validation guidelines [39] to measure BTX co-exposure in traffic wardens 
exposures to automobile exhaust and urban air pollutants examining the urine of men and 
women, including smokers and non-smokers (Table 3). To study urban populations exposed 
to cigarette smoke, Wu et al. [9] used an ultra-high performance small bore column to 
resolved structurally similar mercapturates of acrylonitrile, CEMA and HEMA. UHPLC was 
used ambitiously by Alwis et al. [21] to determine 24 mercapturate metabolites of 15 VOCs 
in the urine of multi-ethnic males and females including both smokers and non-smokers. 
Target mercapturates of this study included a 3rd isomer of 1,3-butadienemercapturate, 4-
hydroxy-2-buteneylmercapturate (MHBMA3). Although multiple analyte analysis is an 
obvious modern trend, the rate of data acquisition must be kept in mind when developing 
and validating new biomarker analytical methods.
4.2. Alkylating agents
The mercapturates of many alkylating agents contain highly polar hydroxyalkyl groups and 
are difficult to retain on RP media. To address this difficulty, Eckert et al. [20] developed a 
HILIC method to determine 6 hydroxyalkyl mercapturates (HAMA), including the first 
reported determination of 2,3-dihydroxypropyl mercapturate of glycidol (Table 3). In 
agreement with earlier reports [28, 58], Eckert reports only 1 MHBMA peak in urine of 
smokers. Most recently, Sterz et al. [16] combined UHPLC with HILIC to separate 1,3-
butadienemercapturate isomers, MHBMA1 and MHBMA2 in human urine (Table 3). 
Altogether, further studies are needed to better evaluate 1,3-butadiene metabolism. Perhaps, 
as in the complementary studies of acrylamide by Dekant and collaborators [6, 7], RPLC-
ESI-MS/MS and HILIC-ESI-MS/MS may be used to investigate the isomers of MHBMA, 
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and evaluate their utility as biomarkers in occupational exposure, in smokers, and in urban 
populations.
4.3. Herbicides
Herbicides are widely used resulting in exposures in commercial, agricultural, urban and 
residential settings. Sensitive, automated high throughput methods for occupational and 
environmental biomonitoring of atrazine (ATZ) exposure have been developed by Barr and 
collaborators [23, 32, 60]. These methods allow simultaneous determination of urinary ATZ, 
ATZ metabolites, their mercapturates and hydroxylated derivatives by combining RP-hexyl 
phenyl chromatography with APCI ionization and multiple precursor-product ion 
monitoring (RP-APCI-MRM). Panuwet et al. [60] adapted this analysis to water and urine 
samples, adding online SPE extraction and concentration of analytes, to determine ATZ, two 
ATZ mercapturates, and four other ATZ metabolites. Kuklenyek et al. [32] expanded 
Panuwet’s online method to create a two-dimensional HPLC analysis that incorporates SAX 
and RP chromatographic separation modes using three multiple-port valves and three 
pumps. This system allows determination of ATZ and 11 ATZ derivatives, including 4 
mercapturates for toxicology and occupational exposure applications. Norrgran et al. [23] 
applied RP-APCI-MRM analysis with a manual mixed-polarity polymeric SPE preparation 
of a 2-ml urine sample to determine multiple herbicides: phenoxyacetate ATZ; 3 
chloroacetanilide herbicides acetochlor, alachlor, metochlor, and their mercapturates. The 
method achieves LODs < 1 μg/L, sufficiently sensitive to detect exposures in non-
occupationally exposed general populations (Table 3).
5. Conclusions
HPLC-MS provides a powerful and useful tool for mercapturic acid quantification. HPLC-
MS allows for a high level of specificity in the analysis method and for the elimination of 
interfering or co-eluting substances found in a biological matrix such as urine. Tandem 
(MS/MS) offers the greatest level of specificity for analysis and will likely be the 
predominant technique utilized for many years to come. The advances in separation 
techniques, such as mixed mode or HILIC, will likely become more widely used as well as 
the utilization of UHPLC as pumping systems become more available commercially and MS 
systems become more versatile and more powerful. Recent applications of HPLC-MS/MS to 
the simultaneous determination of multiple mercapturates as indicators of exposure and 
metabolic processing in individuals may be expected to provide useful information for 
estimating exposure risk in both occupational and environmental health studies.
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Mercapturate formation begins by conjugation of glutathione with an electrophilic group (R) 
of a toxicant or toxicant metabolite with the sulfur of glutathione in the liver or other tissue 
to form a glutathione S-conjugate. Glutamyl and glycine moieties are removed to form a 
cysteine S-conjugate that is N-acetylated to form a specific mercapturate. Adapted from 
Perbellini et al. [3].
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Metabolism of 1-bromopropane in the rat by multiple pathways. 1-bromopropane may be 
directly conjugated with glutathione (GSH) to form n-propyl mercapturate, or 1-
bromopropane may be oxidized to form metabolites which are conjugated with GSH to form 
other mercapturates.
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Table 1
Mercapturate abbreviation and common name by parent compound.
parent compound abbreviation N-acetyl-S-(R)-cysteine




acrylonitrile CEMA 2-cyanoethyl mercapturate
HEMA 2-hydroxyethyl mercapturate
acrolein 3-HPMA 3-hydrosypropyl mercapturate
atrazine AZMA atrazine mercapturate
acetochlor ACMA acetochlor mercapturate
alachlor ALMA alachlor mercapturate
metolachlor MEMA metolachlor mercapturate
benzene PMA phenyl mercapturate
1-bromopropane NPMA n-propyl mercapturate




crotonaldehyde HPMMA 3-hydroxypropyl mercapturate
dimethylacetamide AMMA acetamideomethyl mercapturate
dimethylformamide AMCC n-methylcarbamoyl mercapturate
ethylene oxide HEMA 2-hydroxyethyl mercapturate
glycidol DHPMA 2,3-dihydroxypropyl mercapturate
styrene PHEMA 1-phenyl-2-hydroxyethyl mercapturate
tetrachlorethylene TCVMA trichlorovinyl mercapturate
trichlorethylene 1,2-DCVMA 1,2-dichlorovinyl mercapturate
2,2-DCVMA 2,2-dichlorovinyl mercapturate
toluene BMA benzyl mercapturate
xylene DPMA 2,4-dimethylphenyl mercapturate
MBMA o-methylbenzyl mercapturate
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